Exenatide once weekly: opportunities in the primary care setting.

Postgraduate medicine

Volumn 125, Issue 3, 2013, Pages 68-78

  Davidson, Jaime A ^a   Nikkel, Carla ^b   Grimm, Michael ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; EXENDIN 4; PEPTIDE; VENOM;

BODY WEIGHT; CARDIOVASCULAR DISEASE; DELAYED RELEASE FORMULATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY HEALTH CARE; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; BODY WEIGHT; CARDIOVASCULAR DISEASES; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; PEPTIDES; PRIMARY HEALTH CARE; RISK FACTORS; VENOMS;

EID: 84882240274     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.05.2662     Document Type: Review

References (0)